FreshPatents.com Logo
Enter keywords:  

Track companies' patents here: Public Companies RSS Feeds | RSS Feed Home Page
Popular terms

[SEARCH]

Follow us on Twitter
twitter icon@FreshPatents

Web & Computing
Cloud Computing
Ecommerce
Search patents
Smartphone patents
Social Media patents
Video patents
Website patents
Web Server
Android patents
Copyright patents
Database patents
Programming patents
Wearable Computing
Webcam patents

Web Companies
Apple patents
Google patents
Adobe patents
Ebay patents
Oracle patents
Yahoo patents

[SEARCH]

Vascular patents



      
           
This page is updated frequently with new Vascular-related patents. Subscribe to the Vascular RSS feed to automatically get the update: related Vascular RSS feeds.

Subscribe to updates on this page: Vascular RSS RSS

Date/App# patent app List of recent Vascular-related patents
04/10/14
20140100650
 Endovascular graft for aneurysms involving major branch vessels patent thumbnailEndovascular graft for aneurysms involving major branch vessels
Systems and methods for treating diseased bodily lumens involving branched lumen deployment sites include a main graft or stent-graft deployable in a main artery and a vent device or stent-graft deployable in a branch artery to maintain blood flow through the main artery and from the main artery to the branch artery. Systems and methods for treating diseased bodily lumens involving branched lumen deployment sites may also include a main graft or stent-graft deployable in the main artery, a chimney graft or stent-graft deployable in both branch artery and the main artery to the branch artery and a gutter-sealing device associated with the chimney graft to prevent flow of blood among the chimney graft, the main graft and a wall of the main artery..
04/10/14
20140100648
 Multi-layer vascular prosthesis patent thumbnailMulti-layer vascular prosthesis
A vascular prosthesis comprising a tubular support structure having an outer surface and an internal lumen therethrough, the support structure comprising a base material, which can comprise natural or synthetic materials, the internal lumen surface including an extracellular matrix (ecm) layer that includes at least one ecm material, wherein, when said vascular prosthesis is deployed proximate damaged cardiovascular tissue, the prosthesis induces modulated healing of the damaged tissue. In some embodiments, the support member outer surface also includes an ecm layer..
04/10/14
20140100605
 Apparatus and methods for sealing a vascular puncture patent thumbnailApparatus and methods for sealing a vascular puncture
Apparatus for sealing a puncture communicating with a blood vessel includes a porous carrier formed from lyophilized hydrogel or other material. The plug may include at least first and second hydrogel precursors and a ph adjusting agent carried by the porous carrier in an unreactive state prior to exposure to an aqueous physiological environment.
04/10/14
20140100598
 Vascular device for emboli, thrombus and foreign body removal and methods of use patent thumbnailVascular device for emboli, thrombus and foreign body removal and methods of use
Apparatus and methods are provided for use in filtering emboli from a vessel and/or performing thrombectomy and embolectomy, wherein a vascular device comprises one or more support hoops connected near a distal end of a guide wire, each support hoop having an articulation region, and a blood permeable sac affixed to the support hoop or hoops to form a mouth of the blood permeable sac. The mouth of the sac closes when the apparatus is collapsed for removal to prevent material from escaping from the sac..
04/10/14
20140100562
 Renal nerve modulation devices and methods patent thumbnailRenal nerve modulation devices and methods
Systems for nerve and tissue modulation are disclosed. An example system may include an intravascular nerve modulation system including an elongated shaft having a proximal end region and a distal end region.
04/10/14
20140100552
 Vascular access systems having a guidewire anti-migration feature patent thumbnailVascular access systems having a guidewire anti-migration feature
Disclosed herein is a removable cap for connection to an input port of a catheter, comprising a proximal end having a lumen configured to house a guidewire therethrough; a distal end configured to reversibly mate with a luer lock of the input port of a catheter, the distal end having a lumen configured to house the guidewire therethrough; and a tubular body between the proximal end and the distal end, wherein the tubular body comprises an anti-migration feature transformable between a first configuration to allow slidable movement of the guidewire within the cap in a first direction toward the patient, and a second configuration to prevent slidable movement of the guidewire within the cap in the first direction toward the patient. Systems and methods are also disclosed..
04/10/14
20140100549
 Follow-up of the vascular access of a dialyzed patient patent thumbnailFollow-up of the vascular access of a dialyzed patient
The invention relates to a calculation and control system for the determination of the state of a vascular access of a patient intended to follow successive sessions of extracorporeal blood treatment by extraction and return of the blood via the vascular access, the system comprising: means for determining the value of at least one hemodynamic extracorporeal parameter of the patient for at least two sessions; means for determining the value of the purification effectiveness of the treatment for at least two sessions; programmed means for determining a risk score relating to the state of the vascular access of the patient as a function of at least two values of the hemodynamic extracorporeal parameter and of at least two determined values of the purification effectiveness.. .
04/10/14
20140100508
 Hybrid arteriovenous shunt patent thumbnailHybrid arteriovenous shunt
An apparatus for positioning a graft and catheter operable for subcutaneous access to the vascular system of a patient. A surgically created, hybrid arteriovenous shunt is provided which comprises a flexible graft and a venous outflow catheter connected to the graft via surgical anastomosis over a cuff.
04/10/14
20140100462
 Polarization scrambling for intra-body fiber optic sensor patent thumbnailPolarization scrambling for intra-body fiber optic sensor
In an example, an optical system can include a polarization scrambler coupleable to a tunable first optical source configured to generate a coherent optical output. The system can include an intra-body optical sensor such as a an intravascularly-deliverable optical fiber transducer, configured to be coupled to the tunable first optical source through the polarization scrambler, the polarization scrambler configured to vary a polarization state of the optical energy provided by the tunable first optical source, the intravascularly-deliverable optical fiber transducer configured to reflect a portion of the optical energy modulated in response to a vibration, pressure, or strain.
04/10/14
20140100456
 Methods for localizing implanted vascular access devices patent thumbnailMethods for localizing implanted vascular access devices
Disclosed are vascular access devices, implantable dialysis grafts, and systems including them useful for improved access to implanted medical devices. Also disclosed are implantable hemodialysis vascular access graft devices that facilitate easy, accurate and reproducible cannulation or needle entry into the implanted device by magnetically-locating a portion of the graft that includes one or more paramagnetic materials operably defining the physical boundaries of the target cannulation site/entry port..
04/10/14
20140100443
System and method for imaging of the vascular components with temporal information and suppressed blood pools using magnetic resonance imaging
A system and method is provided that includes a) monitoring a cardiac cycle of the subject to identify a predetermined point and, b) upon identifying the predetermined point, performing the steps of i) performing at least one of a desired number of magnetization suppressing preparations to suppress signal from blood flow through at least the region of interest, ii) acquiring a first set of imaging data from the region of interest, and iii) repeating step i) and step ii) to acquire at least a second set of imaging data from the region of interest. The method further includes c) repeating step b) a predetermined number of times over a series of cardiac cycles to acquire respective sets of medical imaging data of the region of interest and d) reconstructing first set of imaging data and the second set of imaging data into a time-resolved series of images..
04/10/14
20140100411
Treatment of cardiovascular disorders with targeted nanoparticles
Methods for treating various cardiovascular disorders include targeted delivery of calcium ions for permanently impairing a portion of the autonomic nervous system (ans). Targeted delivery may be via magnetically-targetable nanoparticles..
04/10/14
20140100289
Methods and compositions for treating mammalian nerve tissue injuries
To achieve, an in vivo repair of injured mammalian nerve tissue, an effective amount of a biomembrane fusion agent is administered to the injured nerve tissue. The application of the biomembrane fusion agent may be performed by directly contacting the agent with the nerve tissue at the site of the injury.
04/10/14
20140100281
Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids, wherein at least 50% by weight of the fatty acids comprise omega-3-fatty acids, salts or derivatives thereof, wherein the omega-3 fatty acids comprise eicosapentaenoic acid (epa; c20:5-n3), docosapentaenoic acid (dpa; c22:5-n3), and docosahexaenoic acid (dha; c22:6-n3), wherein the ratio of dha to epa (dha:epa) is less than 1:20, and wherein the ratio of dha to dpa (dha:dpa) is less than 2:1 are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/10/14
20140100258
Methods for treating degenerative diseases/injuries
Invented is a method of treating cardiovascular disease/injury, in a mammal, including a human, in need thereof which comprises the administration of a therapeutically effective amount of a non-peptide tpo receptor agonist to such mammal.. .
04/10/14
20140100243
Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use
The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridine-3-carboxamides, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.. .
04/10/14
20140100234
Quinoline derivatives as pi3 kinase inhibitors
Invented is a method of inhibiting the activity/function of pi3 kinases using quinoline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoline derivatives..
04/10/14
20140100229
Fluoroalkyl-substituted pyrazolopyridines and use thereof
The present application relates to novel fluoroalkyl-substituted pyrazolopyridines, to processes for their preparation, to their use, alone or in combinations, for the treatment and/or prophylaxis of diseases and to their use for production of medicaments for the treatment and/or prophylaxis of diseases, especially for the treatment and/or prophylaxis of cardiovascular disorders.. .
04/10/14
20140100216
Stimulators of incretin hormones secretion, method for preparation and use thereof
The invention relates to the area of medicinal chemistry, pharmacology and medicine and includes description of pharmaceutical compositions and combined medicaments on the base of secretion stimulators and protectors of incretin hormones for treatment of metabolic diseases (among them, diabetes, obesity, metabolic syndrome and the like). The invention consists in that that pharmaceutical composition or combined medicament comprises a derivative of tetrahydrobenzo[f][1,4]oxazepine—either nonsteroidal agonist of bile aids receptor tgr5, or one of endogenous bile acids which stimulate incretin hormones secretion, and also one of the known inhibitors of dpp-iv proteinase.
04/10/14
20140100191
Vesicular formulations
Disclosed herein are vesicular formulations that include one or more phospholipids and one or more surfactants and in certain embodiments the use of such formulations for the delivery of fatty acids for the treatment of disorders such as, fatty acid metabolic disorders, including essential fatty acid deficiency; pain or inflammation or osteoarthritis, more specifically for the treatment of deep tissue pain; asthma, bronchospasm, atherothrombatic cardiovascular disorders, avenous thrombatic disorders, inflammatory dermatoses disorders (e.g., atopic eczema, dishydrotic hand eczema, plaque type psoriasis, seborrheic eczema, and acne vulgaris), and dysmenorrhea.. .
04/10/14
20140100167
Assessment of cardiac health and thrombotic risk in a patient
The invention features methods and compositions for assessing risk, particularly immediate risk, of thrombotic events in patients with suspected or known vascular disease, and more particularly to assessing risk of thrombotic events in patients with coronary artery disease, particularly acute myocardial infarction, stroke, unstable angina, stable angina, or restenosis. Risk of thrombosis can be assessed by analysis of platelet reactivity and/or velocity of thrombin or fibrin formation, and determining whether the patient has a score associated above a risk threshold value.
04/10/14
20140100128
Use of markers in the identification of cardiotoxic agents and in the diagnosis and monitoring of cardiomyopathy and cardiovascular disease
The invention provides methods for the diagnosis and prognosis of cardiovascular disease, and for monitoring of the treatment of cardiovascular disease, including heart failure and cardiomyopathy. The invention further provides methods for identifying an agent for treating cardiomyopathy or heart failure, for identifying a cardiotoxic agent, and for identifying a rescue agent to reduce or prevent drug-induced toxicity, by using one or more biomarkers selelcted from the group consisting of ccdc47, hmox1, ptx3, pai1, il27, igfbp7, emmprin, cfl2, edil3, nucb1, pe d18:0-20:3/d18:1-20:2/d16:0-22:3; pe d18:0-22:5/d18:1-22:4; pe d16:1-22:6; pe p18:1-18:1/p18:0-18:2/p16:0-20:2; lpc 20:3; and pc-li-183-d18:22-22:6, or any of the other biomarkers provided herein.
04/10/14
20140099633
Detection of mirna using capillary electrophoresis with laser-induced fluorescence detection
Disclosed is a method for detecting a mirna present in a sample in trace amounts and a kit for detecting the same. According to the present invention, the mirna present in the sample in trace amounts can be quantitatively analyzed in short time.
04/10/14
20140099620
Modular pulse duplicator system for simulation of cardiovascular hemodynamic functions
A versatile multi-function modular pulse duplicator system having multiple modules each universally and fluidly connected to each other via universal connectors. Each module being detachable from another module and the plurality of modules can be rearranged in different sequence or quantity as the user desires for specifically designed hemodynamic simulations.
04/10/14
20140099329
Treatment of diseases and disorders using self-renewing colony forming cells cultured and expanded in vitro
The present invention relates to methods and uses of cells for the prevention and treatment of a wide variety of diseases and disorders and the repair and regeneration of tissues and organs using low passage and extensively passaged in vitro cultured, self-renewing, colony forming somatic cells (cf-sc). For example, adult bone marrow-derived somatic cells (abm-sc), or compositions produced by such cells, are useful alone or in combination with other components for treating, for example, cardiovascular, neurological, integumentary, dermatological, periodontal, and immune mediated diseases, disorders, pathologies, and injuries..
04/10/14
20140099321
Treating vascular disease and complications thereof
Administration of an antibody that specifically binds il-1α is useful for reducing the chance or severity of a major adverse clinical event occurring in a mammalian subject having received or expected to receive surgical treatment for a stenosed blood vessel, and for reducing the chance of restenosis occurring (or increasing the time until restenosis occurs) in a mammalian subject having received or expected to receive surgical treatment for a stenosed blood vessel.. .
04/10/14
20140099292
Cd14+ cell compositions and methods of using same
The present invention provides cd 14+ cell compositions and methods of using same in treating disorders, such as inflammatory disorders, such as atherosclerosis and cardiovascular disease.. .
04/10/14
20140099289
Tissue-engineered endothelial and epithelial implants differentially and synergistically regulate tissue repair
Endothelial implants restore vascular homeostasis after injury without reconstituting vascular architecture. Endothelial cells line the vascular epithelium and underlying vasa vasorum precluding distinction between cellular controls.
04/10/14
20140099280
Novel superactive il-33 fragments, and uses thereof
The present invention discloses novel active polypeptide fragments of human il-33 corresponding to natural forms generated by the proteases of human neutrophils (cathepsin g, elastase 2, proteinase 3), as well as the use thereof as a drug, in particular for the treatment of infectious diseases, inflammatory diseases, atherosclerosis, cardiovascular diseases, obesity, or cancer.. .
04/10/14
20140097277
Biodegradable iron-containing compositions, methods of preparing and applications therefor
The invention relates to biodegradable iron alloy-containing compositions for use in preparing medical devices. In addition, biodegradable crystalline and amorphous compositions of the invention exhibit properties that make them suitable for use as medical devices for implantation into a body of a patient.
04/03/14
20140094904
Retrievable heart valve anchor and method
A method for endovascularly replacing a heart valve of a patient. In some embodiments the method includes the steps of: endovascularly delivering a replacement valve and an expandable anchor in an unexpanded configuration within a catheter to a vicinity of the heart valve; deploying the anchor from the catheter; expanding the anchor to contact tissue at an anchor site; and retrieving the anchor into the catheter.
04/03/14
20140094902
Vascular endograft
An endograft includes a main body having a wall separating interior and exterior surfaces and adapted to be inserted within the vessel. The main body is characterized by a single proximal opening and two distal openings and at least one aperture extending through the wall.
04/03/14
20140094901
Radiopaque marker for vascular devices
A marker to assist locating a device such as an expandable stent within vasculature of a patient, including an elongated body formed of a biocompatible radiopaque material that enhances locating the marker when using at least one imaging technique. The body has a first end, a second end, an inner surface, an outer surface, and at least two opposing edges extending between the first and second ends and establishing a boundary between the inner surface and the outer surface.
04/03/14
20140094900
Compliant biocompatible device and method of manufacture
As detailed herein, a biocompatible apparatus comprises a porous material comprising ceramic nanotubes bound together with a filler material. The proportion of the filler material may be selected to provide porosity for the porous material that is biocompatible, and the porous material may be shaped to provide a compliant biomedical device.
04/03/14
20140094896
Vascular stenting for aneurysms
Described herein are flexible implantable occluding devices that can, for example, navigate the tortuous vessels of the neurovasculature. The occluding devices can also conform to the shape of the tortuous vessels of the vasculature.
04/03/14
20140094883
Intravascular heat exchange catheter with rib cage-like coolant path
An intravascular heat exchange catheter has serpentine-like supply and return conduits circulating working fluid with a heat exchange system to warm or cool a patient in which the catheter is intubated.. .
04/03/14
20140094882
Intravascular heat exchange catheter with non-round coiled coolant path
A catheter has a hollow conduit through which working fluid from a heat exchange system flows. The conduit in turn is configured to extend along a longitudinal central axis in a continuously varying non-constant azimuthal orientation so that it defines a non-round enclosed passageway through which blood can flow to exchange heat through a wall of the conduit with the working fluid flowing within the conduit..
04/03/14
20140094881
Intravascular heat exchange catheter and system with rfid coupling
A system includes a heat exchange catheter line assembly configured to convey working fluid circulating to and from at least one heat exchange element on an intravascular heat exchange catheter. The system also includes a heat exchange system that itself includes a processor and is configured for fluidly communicating with the heat exchange catheter line assembly to exchange heat with the working fluid.
04/03/14
20140094880
Intravascular heat exchange catheter with multiple spaced apart discrete coolant loops
A catheter has a series of hollow loops arranged along a tube for carrying working fluid from a heat exchange system to exchange heat with a patient in whom the catheter is advanced. The loops when inflated are transverse to the catheter axis and parallel to each other, and circumscribe a hollow passageway through which blood can flow.
04/03/14
20140094846
Vascular closure device with a plug having a variable expansion rate and method for using the same
A vascular closure device, having an insertion sheath and a vascular closure implant positioned at least partially in the insertion sheath. The vascular closure implant may have an anchor element, the anchor element including an expandable material, a first puncture contact portion, a bend portion connected to the first puncture contact portion, the bend portion including a bend, and a second puncture contact portion connected to the bend portion.
04/03/14
20140094841
Clot removal device for deep vein thrombosis
The invention being disclosed describes a medical device for removal of a thrombus or clot in a vascular setting by using a rotational, expandable basket structure in combination with drug infusion, blood/particle aspiration and clot isolation by distal and proximal occlusion.. .
04/03/14
20140094809
Method of reducing sidewall compaction in a bone or articular joint penetration
A method of creating a penetration with reduced sidewall compaction in a surface of a bone or articular joint. The method includes the steps of positioning a surgical instrument in contact with the surface, applying a longitudinal force to the surgical instrument causing the surgical instrument to penetrate the surface thereby creating a penetration with at least one sidewall, and retracting the surgical instrument and strategically scraping a portion of the surgical instrument against a portion of the at least one sidewall to remove compacted material from the penetration, thereby creating a small surgically created wound in the surface having reduced compaction at the margins to promote rapid vascular penetration, cellular migration, and faster healing with an enhanced histologically confirmed maturing tissue.
04/03/14
20140094806
Surgical instrument for penetrating removing bone
A surgical instrument whose cutting portion is a sharp miniature chisel or awl shape with a series of ridges along the course of the cutting tool. Each ridge has, on its proximal surface, a concave surface.
04/03/14
20140094726
Vascular compression system
A vascular compression system includes a compression garment and a controller for compressing a body part of a person. In some embodiments, the compression garment is a foot cuff or a leg sleeve.
04/03/14
20140094670
Methods and systems for monitoring respiration with photoplethysmography
The present invention relates to novel lip/cheek probes for detection of pulse-based differences in light absorbence across the vascularized tissue of a lip or cheek of a patient. These probes are fabricated to provide signals to estimate arterial oxygen saturation, and/or to obtain other photoplethysmographic data.
04/03/14
20140094520
Omega-3 pentaenoic acid compositions and methods of use
Orally administrable composition comprising fatty acids, wherein at least 50% by weight of the fatty acids comprise omega-3-fatty acids, salts or derivatives thereof, wherein the omega-3 fatty acids comprise eicosapentaenoic acid (epa; c20:5-n3), docosapentaenoic acid (dpa; c22:5-n3), and docosahexaenoic acid (dha; c22:6-n3), wherein the ratio of dha to epa (dha:epa) is less than 1:20, and wherein the ratio of dha to dpa (dha:dpa) is less than 2:1 are provided. These compositions can be used for the treatment or prophylaxis of dyslipidemic, cardiovascular, cns, inflammatory, and other diseases/conditions or risk factors therefore..
04/03/14
20140094502
Rnai inhibition of ctgf for treatment of ocular disorders
Rna interference is provided for inhibition of connective tissue growth factor mrna expression in ocular disorders involving ctgf expression. Ocular disorders involving aberrant ctgf expression include glaucoma, macular degeneration, diabetic retinopathy, choroidal neovascularization, proliferative vitreoretinopathy and wound healing.
04/03/14
20140094493
Novel ether linked compounds and improved treatments for cardiac and cardiovascular disease
Their preparation and novel intermediates, compositions thereof and their use in the prevention or treatment of cardiac and cardiovascular disease and methods for the treatment thereof.. .
04/03/14
20140094460
Fused heterocyclic compounds as ion channel modulators
In which r1, r2, r3, r4, r5, r6, and r7 are as defined above, and to their use in the treatment of various disease states, including cardiovascular diseases and diabetes.. .
04/03/14
20140094444
Compositions and methods for tissue engineering and cell based therapies
The present application discloses strategies to recruit and mobilize stem cells using s1p receptor selective agonists and antagonists as wells as regulators of chemokine receptors. In an in vivo ischemic model, s1p1/s1p3 activation with fty720 impeded inflammatory cell infiltration and recruited endothelial progenitor cells (epcs) with the potential to increase microvascular remodeling.
04/03/14
20140094381
Predictive biomarkers for response to exercise
A set of biomarkers have been identified that allows one to predict subjects who will respond to an exercise regime in term of cardiorespiratory fitness as assessed by maximal oxygen uptake. These predictions may be used, for example, to predict risk of cardiovascular disease, to design a more effective program for cardiac rehabilitation, to predict capacity for athletic performance or physically demanding occupation, and to predict ability to maintain functional capacity with aging using exercise..


Popular terms: [SEARCH]



Follow us on Twitter
twitter icon@FreshPatents

###

This listing is a sample listing of patents related to Vascular for is only meant as a recent sample of applications filed, not a comprehensive history. There may be associated servicemarks and trademarks related to these patents. Please check with patent attorney if you need further assistance or plan to use for business purposes. This patent data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Vascular with additional patents listed. Browse our RSS directory or Search for other possible listings.
     SHARE
  
         


FreshNews promo



0.305

4771

3 - 0 - 99